ӳ��ý

Publications

Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets.

Kołodziejczak-Guglas I, Simões RLS, Santos E de S, et al. Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets. Cell genomics. 2025:100851. doi:10.1016/j.xgen.2025.100851

Safeguarding genomic imprints in naive human pluripotency.

Angeles ADL. Safeguarding genomic imprints in naive human pluripotency. Stem cell reports. 2025:102475. doi:10.1016/j.stemcr.2025.102475

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.

German J, Cordioli M, Tozzo V, et al. Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery. Nature medicine. 2025. doi:10.1038/s41591-025-03645-3

Systemic inflammation impairs myelopoiesis and interferon type I responses in humans.

Keramati F, Leijte GP, Bruse N, et al. Systemic inflammation impairs myelopoiesis and interferon type I responses in humans. Nature immunology. 2025. doi:10.1038/s41590-025-02136-4

Mitochondrial DNA variant detection in over 6,500 rare disease families by the systematic analysis of exome and genome sequencing data resolves undiagnosed cases.

Stenton SL, Laricchia K, Lake NJ, et al. Mitochondrial DNA variant detection in over 6,500 rare disease families by the systematic analysis of exome and genome sequencing data resolves undiagnosed cases. HGG advances. 2025:100441. doi:10.1016/j.xhgg.2025.100441

Trends in Risk Factor Management Among Stroke Survivors in a Representative US Population.

Tack RWP, Senff JR, Tan BY, et al. Trends in Risk Factor Management Among Stroke Survivors in a Representative US Population. American journal of lifestyle medicine. 2025:15598276251333369. doi:10.1177/15598276251333369

variants contribute to FSGS susceptibility across multiple populations.

Skitchenko R, Modrusan Z, Loboda A, et al. variants contribute to FSGS susceptibility across multiple populations. iScience. 2025;28(4):112234. doi:10.1016/j.isci.2025.112234

Modulating Collagen I Expression in Fibroblasts by CRISPR-Cas9 Base Editing of the Collagen 1A1 Promoter.

Daliri K, Hescheler J, Newby GA, Clement K, Liu DR, Pfannkuche K. Modulating Collagen I Expression in Fibroblasts by CRISPR-Cas9 Base Editing of the Collagen 1A1 Promoter. International journal of molecular sciences. 2025;26(7). doi:10.3390/ijms26073041

Rewriting regulatory DNA to dissect and reprogram gene expression.

Martyn GE, Montgomery MT, Jones H, et al. Rewriting regulatory DNA to dissect and reprogram gene expression. Cell. 2025. doi:10.1016/j.cell.2025.03.034

The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation.

Polonio CM, McHale KA, Sherr DH, Rubenstein D, Quintana FJ. The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation. Nature reviews. Drug discovery. 2025. doi:10.1038/s41573-025-01172-x